FDA Finalizes Guidance On ‘Unique Challenges’ Of Psychedelic Research And Schedules Hearing On Therapeutic Uses
April 9, 2017 Bipartisan Bill Would Reclassify Marijuana as Schedule 3 Substance Bipartisan legislation proposed in the House on Thursday would make marijuana a Schedule 3 drug
